Enclosed disclosure under Regulation 30 of SEBI Listing Regulations, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
On August 7, 2025, Pharmaids Pharmaceuticals announced key management changes following a board meeting. Dr. S Prasad resigned as Chief Executive Officer effective close of business on the same day, citing personal reasons, and also ceased to be a Key Managerial Personnel. The company appointed three Senior Management Personnel: Dr. Sidde Gowda (30+ years of pharma experience with GSK, Apotex, Sami Sabinsa) as VP – Operations, Dr. Jagadeesh M (20+ years in drug discovery CRO, 10+ international patents) as VP – Discovery Services, and Mr. Shivananda Murthy (35 years in IT/CRO industry, ex-Eurofins Advinus, ex-Bioneeds) as Chief Information Officer. No new CEO has been appointed as of the filing date. The board meeting ran from 3:30 PM to 4:20 PM.
The sudden CEO exit without an immediate replacement creates short-term leadership uncertainty, though the company has simultaneously strengthened its senior bench across operations, discovery, and IT. Retail investors should watch for a forthcoming CEO appointment announcement to assess continuity in strategy.